TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
However, tests results can be false when they give a result that does not match the reality of the disease
Glutathione supplements help in improving the bodys immunological response, thereby reducing the occurrence of autoimmune diseases
ARA290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic pain in spontaneous type 2 diabetes
Runners with this condition typically experience pain directly at the back of the heel, often accompanied by bony prominence or calcification
